Year |
Citation |
Score |
2021 |
Negrao MV, Skoulidis F, Montesion M, Schulze K, Bara I, Shen V, Xu H, Hu S, Sui D, Elamin YY, Le X, Goldberg ME, Murugesan K, Wu CJ, Zhang J, et al. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer. Journal For Immunotherapy of Cancer. 9. PMID 34376553 DOI: 10.1136/jitc-2021-002891 |
0.305 |
|
2013 |
Le X, Pugach EK, Hettmer S, Storer NY, Liu J, Wills AA, DiBiase A, Chen EY, Ignatius MS, Poss KD, Wagers AJ, Langenau DM, Zon LI. A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma development. Development (Cambridge, England). 140: 2354-64. PMID 23615277 DOI: 10.1242/Dev.088427 |
0.531 |
|
2008 |
Zon LI, Le X. Potential of zebrafish for anticancer drug screening. Expert Opinion On Drug Discovery. 3: 1451-60. PMID 23506108 DOI: 10.1517/17460440802580171 |
0.453 |
|
2007 |
Le X, Langenau DM, Keefe MD, Kutok JL, Neuberg DS, Zon LI. Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proceedings of the National Academy of Sciences of the United States of America. 104: 9410-5. PMID 17517602 DOI: 10.1073/Pnas.0611302104 |
0.617 |
|
2007 |
Langenau DM, Keefe MD, Storer NY, Guyon JR, Kutok JL, Le X, Goessling W, Neuberg DS, Kunkel LM, Zon LI. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes & Development. 21: 1382-95. PMID 17510286 DOI: 10.1101/Gad.1545007 |
0.527 |
|
Show low-probability matches. |